Marsh & McLennan Companies (NYSE:MMC – Get Free Report) posted its quarterly earnings results on Thursday. The financial services provider reported $1.87 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.12, Zacks reports. Marsh & McLennan Companies had a net margin of 16.82% and a return on equity of 32.65%.
Marsh & McLennan Companies Stock Performance
NYSE:MMC traded up $0.64 during mid-day trading on Thursday, hitting $219.14. The stock had a trading volume of 913,056 shares, compared to its average volume of 1,973,350. Marsh & McLennan Companies has a 52 week low of $190.41 and a 52 week high of $235.50. The stock has a market capitalization of $107.62 billion, a price-to-earnings ratio of 26.99, a P/E/G ratio of 2.27 and a beta of 0.96. The company has a 50 day simple moving average of $217.95 and a 200-day simple moving average of $221.40. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.89.
Marsh & McLennan Companies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Thursday, January 30th will be given a $0.815 dividend. The ex-dividend date of this dividend is Thursday, January 30th. This represents a $3.26 annualized dividend and a yield of 1.49%. Marsh & McLennan Companies’s dividend payout ratio is presently 40.15%.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- How Value Investors Find Undervalued Stocks and Build Wealth
- How to Calculate Inflation Rate
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- Election Stocks: How Elections Affect the Stock Market
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.